Low-level Light Therapy for Treatment of Diabetic Foot Ulcer: A Review of Clinical Experiences

Catherine N. Tchanque-Fossuo, Derek Ho, Sara E. Dahle, Eugene Koo, Roslyn Rivkah Isseroff, Jared Jagdeo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

BACKGROUND: Diabetic foot ulcers (DFU) represent a significant complication of diabetes mellitus (DM). DFU affect one in four patients with DM and treatments of DFU are limited and challenging. The management of DFU remains a significant healthcare and socioeconomic burden ($245 billion). There is a wide range of advanced therapies for DFU, but these are costly and have demonstrated only minimal efficacy in limited published studies. An emerging treatment modality to improve DFU and optimize wound healing is the use of low-level light therapy (LLLT). LLLT involves the use of light in the form of low-level or low-power laser or light emitting diodes to alter biochemical pathways, which may result in changes to cell shape, cell migration, and cell signaling.

OBJECTIVE: To review published clinical experiences (case series and case reports) using LLLT for treatment of DFU, and provide evidence-based recommendations and future directions on the potential of LLLT as a therapeutic modality for DFU.

METHODS AND MATERIALS: On January 16, 2016 we searched the published literature using databases: PubMed, EMBASE, CINAHL, and Web of Science with key terms: "diabetic foot" AND ("low level laser therapy" OR "low level light therapy" OR "LLLT" OR "light emitting diode" OR "phototherapy" OR "laser").

RESULTS: After screening of titles, abstracts and/or full-text, 7 original articles were suitable in our review. Our review contains 5 case series and 2 case reports that evaluated LLLT for treatment of DFU, and all reviewed studies have shown positive improvement of DFU using LLLT with no adverse events, albeit with limitations that may be minimized with future RCTs.

CONCLUSIONS: LLLT is an emerging and promising treatment modality to current alternatives that are costly and have shown limited success. Based upon the published evidence, we envision additional research may allow for stronger recommendation with LLLT for treatment of DFU.

J Drugs Dermatol. 2016;15(7):843-848.

Original languageEnglish (US)
Pages (from-to)843-848
Number of pages6
JournalJournal of drugs in dermatology : JDD
Volume15
Issue number7
StatePublished - Jul 1 2016

Fingerprint

Diabetic Foot
Therapeutics
Light
Low-Level Light Therapy
Cell Shape
Diabetes Complications
PubMed
Wound Healing
Cell Movement
Diabetes Mellitus
Lasers

ASJC Scopus subject areas

  • Medicine(all)
  • Dermatology

Cite this

Low-level Light Therapy for Treatment of Diabetic Foot Ulcer : A Review of Clinical Experiences. / Tchanque-Fossuo, Catherine N.; Ho, Derek; Dahle, Sara E.; Koo, Eugene; Isseroff, Roslyn Rivkah; Jagdeo, Jared.

In: Journal of drugs in dermatology : JDD, Vol. 15, No. 7, 01.07.2016, p. 843-848.

Research output: Contribution to journalArticle

Tchanque-Fossuo, Catherine N. ; Ho, Derek ; Dahle, Sara E. ; Koo, Eugene ; Isseroff, Roslyn Rivkah ; Jagdeo, Jared. / Low-level Light Therapy for Treatment of Diabetic Foot Ulcer : A Review of Clinical Experiences. In: Journal of drugs in dermatology : JDD. 2016 ; Vol. 15, No. 7. pp. 843-848.
@article{6789d77205fe4406b66031f93b3ed7f0,
title = "Low-level Light Therapy for Treatment of Diabetic Foot Ulcer: A Review of Clinical Experiences",
abstract = "BACKGROUND: Diabetic foot ulcers (DFU) represent a significant complication of diabetes mellitus (DM). DFU affect one in four patients with DM and treatments of DFU are limited and challenging. The management of DFU remains a significant healthcare and socioeconomic burden ($245 billion). There is a wide range of advanced therapies for DFU, but these are costly and have demonstrated only minimal efficacy in limited published studies. An emerging treatment modality to improve DFU and optimize wound healing is the use of low-level light therapy (LLLT). LLLT involves the use of light in the form of low-level or low-power laser or light emitting diodes to alter biochemical pathways, which may result in changes to cell shape, cell migration, and cell signaling.OBJECTIVE: To review published clinical experiences (case series and case reports) using LLLT for treatment of DFU, and provide evidence-based recommendations and future directions on the potential of LLLT as a therapeutic modality for DFU.METHODS AND MATERIALS: On January 16, 2016 we searched the published literature using databases: PubMed, EMBASE, CINAHL, and Web of Science with key terms: {"}diabetic foot{"} AND ({"}low level laser therapy{"} OR {"}low level light therapy{"} OR {"}LLLT{"} OR {"}light emitting diode{"} OR {"}phototherapy{"} OR {"}laser{"}).RESULTS: After screening of titles, abstracts and/or full-text, 7 original articles were suitable in our review. Our review contains 5 case series and 2 case reports that evaluated LLLT for treatment of DFU, and all reviewed studies have shown positive improvement of DFU using LLLT with no adverse events, albeit with limitations that may be minimized with future RCTs.CONCLUSIONS: LLLT is an emerging and promising treatment modality to current alternatives that are costly and have shown limited success. Based upon the published evidence, we envision additional research may allow for stronger recommendation with LLLT for treatment of DFU. J Drugs Dermatol. 2016;15(7):843-848.",
author = "Tchanque-Fossuo, {Catherine N.} and Derek Ho and Dahle, {Sara E.} and Eugene Koo and Isseroff, {Roslyn Rivkah} and Jared Jagdeo",
year = "2016",
month = "7",
day = "1",
language = "English (US)",
volume = "15",
pages = "843--848",
journal = "Journal of Drugs in Dermatology",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "7",

}

TY - JOUR

T1 - Low-level Light Therapy for Treatment of Diabetic Foot Ulcer

T2 - A Review of Clinical Experiences

AU - Tchanque-Fossuo, Catherine N.

AU - Ho, Derek

AU - Dahle, Sara E.

AU - Koo, Eugene

AU - Isseroff, Roslyn Rivkah

AU - Jagdeo, Jared

PY - 2016/7/1

Y1 - 2016/7/1

N2 - BACKGROUND: Diabetic foot ulcers (DFU) represent a significant complication of diabetes mellitus (DM). DFU affect one in four patients with DM and treatments of DFU are limited and challenging. The management of DFU remains a significant healthcare and socioeconomic burden ($245 billion). There is a wide range of advanced therapies for DFU, but these are costly and have demonstrated only minimal efficacy in limited published studies. An emerging treatment modality to improve DFU and optimize wound healing is the use of low-level light therapy (LLLT). LLLT involves the use of light in the form of low-level or low-power laser or light emitting diodes to alter biochemical pathways, which may result in changes to cell shape, cell migration, and cell signaling.OBJECTIVE: To review published clinical experiences (case series and case reports) using LLLT for treatment of DFU, and provide evidence-based recommendations and future directions on the potential of LLLT as a therapeutic modality for DFU.METHODS AND MATERIALS: On January 16, 2016 we searched the published literature using databases: PubMed, EMBASE, CINAHL, and Web of Science with key terms: "diabetic foot" AND ("low level laser therapy" OR "low level light therapy" OR "LLLT" OR "light emitting diode" OR "phototherapy" OR "laser").RESULTS: After screening of titles, abstracts and/or full-text, 7 original articles were suitable in our review. Our review contains 5 case series and 2 case reports that evaluated LLLT for treatment of DFU, and all reviewed studies have shown positive improvement of DFU using LLLT with no adverse events, albeit with limitations that may be minimized with future RCTs.CONCLUSIONS: LLLT is an emerging and promising treatment modality to current alternatives that are costly and have shown limited success. Based upon the published evidence, we envision additional research may allow for stronger recommendation with LLLT for treatment of DFU. J Drugs Dermatol. 2016;15(7):843-848.

AB - BACKGROUND: Diabetic foot ulcers (DFU) represent a significant complication of diabetes mellitus (DM). DFU affect one in four patients with DM and treatments of DFU are limited and challenging. The management of DFU remains a significant healthcare and socioeconomic burden ($245 billion). There is a wide range of advanced therapies for DFU, but these are costly and have demonstrated only minimal efficacy in limited published studies. An emerging treatment modality to improve DFU and optimize wound healing is the use of low-level light therapy (LLLT). LLLT involves the use of light in the form of low-level or low-power laser or light emitting diodes to alter biochemical pathways, which may result in changes to cell shape, cell migration, and cell signaling.OBJECTIVE: To review published clinical experiences (case series and case reports) using LLLT for treatment of DFU, and provide evidence-based recommendations and future directions on the potential of LLLT as a therapeutic modality for DFU.METHODS AND MATERIALS: On January 16, 2016 we searched the published literature using databases: PubMed, EMBASE, CINAHL, and Web of Science with key terms: "diabetic foot" AND ("low level laser therapy" OR "low level light therapy" OR "LLLT" OR "light emitting diode" OR "phototherapy" OR "laser").RESULTS: After screening of titles, abstracts and/or full-text, 7 original articles were suitable in our review. Our review contains 5 case series and 2 case reports that evaluated LLLT for treatment of DFU, and all reviewed studies have shown positive improvement of DFU using LLLT with no adverse events, albeit with limitations that may be minimized with future RCTs.CONCLUSIONS: LLLT is an emerging and promising treatment modality to current alternatives that are costly and have shown limited success. Based upon the published evidence, we envision additional research may allow for stronger recommendation with LLLT for treatment of DFU. J Drugs Dermatol. 2016;15(7):843-848.

UR - http://www.scopus.com/inward/record.url?scp=85015608045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015608045&partnerID=8YFLogxK

M3 - Article

C2 - 27391634

AN - SCOPUS:85015608045

VL - 15

SP - 843

EP - 848

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

SN - 1545-9616

IS - 7

ER -